Completed NA INTERVENTIONAL 2-arm NCT02404103

Flunisolide HFA in Children With Small Airway Disease

Sponsor: Meda Pharmaceuticals

Updated 8 times since 2017 Last updated: Dec 13, 2017 Started: Mar 31, 2015 Primary completion: May 31, 2017 Completion: Jun 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02404103, this NA trial focuses on Childhood Asthma and remains completed. Sponsored by Meda Pharmaceuticals, it has been updated 8 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Dec 2021 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 3 earlier versions

Nov 2017 — Jun 2018 [monthly]

Completed NA

Status: Recruiting → Completed
Feb 2017 — Nov 2017 [monthly]

Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Meda Pharmaceuticals
University of Louisville

Data source: University of Louisville

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Louisville, United States